Sequana Medical NV (Sequana Medical NV) Gross-Profit-to-Asset % : 4.69% (As of Jun. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Sequana Medical NV Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Sequana Medical NV's annualized Gross Profit for the quarter that ended in Jun. 2023 was $1.28 Mil. Sequana Medical NV's average Total Assets over the quarter that ended in Jun. 2023 was $27.40 Mil. Therefore, Sequana Medical NV's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2023 was 4.69%.

Sequana Medical NV Gross-Profit-to-Asset % Historical Data

The historical data trend for Sequana Medical NV's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequana Medical NV Gross-Profit-to-Asset % Chart

Sequana Medical NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

24.88

12.11

6.69

1.96

3.44

Sequana Medical NV Quarterly Data
	Dec15	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial									0.36	5.25	6.23	5.04	4.69

Competitive Comparison of Sequana Medical NV's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Sequana Medical NV's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sequana Medical NV's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sequana Medical NV's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Sequana Medical NV's Gross-Profit-to-Asset % falls into.

Sequana Medical NV Gross-Profit-to-Asset % Calculation

Sequana Medical NV's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2022 )	/	( (Total Assets (A: Dec. 2021 )	+	Total Assets (A: Dec. 2022 ))	/ count )
	=	0.761	/	( (16.616	+	27.569)	/ 2 )
	=	0.761	/	22.0925
	=	3.44 %

Sequana Medical NV's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Jun. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Jun. 2023 ))	/ count )
	=	1.284	/	( (27.569	+	27.223)	/ 2 )
	=	1.284	/	27.396
	=	4.69 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Jun. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Sequana Medical NV Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Sequana Medical NV's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sequana Medical NV (Sequana Medical NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sequana Medical NV (GREY:SQNMF) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

2SE:Germany SEQUA:Belgium

Address

Kortrijksesteenweg 1112 ,bus 102, Sint-Denijs-Westrem, Ghent, BEL, 9051

Website

https://www.sequanamedical.com

Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies and over 750 implants. The company's geographical segments include Switzerland, Germany, the United Kingdom, and the Rest of the world, out of which Germany accounts for the majority of the revenue.

Sequana Medical NV (Sequana Medical NV) Headlines

No Headlines